RxDoctor Payments Data

David Lahue, MD

Internal Medicine · Columbus, OHNPI 1861476327

Payments from drug & device makers

$6,484in general payments, 2019–2025

Across 446 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$910
  • GSK$568
  • Lilly USA, LLC$406
  • Pfizer$400
  • AstraZeneca$390
  • plus $2K from 36 others

What the payments were for

  • Food & beverage$6,44699%
  • Education$381%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,484 in reported general payments places this provider in the 90th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$69,225
Medicare patients
249
Services billed
1,971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban127$148,914
OzempicSemaglutide61$85,495
XareltoRivaroxaban60$60,433
FarxigaDapagliflozin Propanediol38$33,691
JardianceEmpagliflozin26$30,869
TrulicityDulaglutide23$25,741
MyrbetriqMirabegron18$15,972
Spiriva RespimatTiotropium Bromide16$14,531
Breo ElliptaFluticasone/Vilanterol21$11,446
Tresiba Flextouch U-100Insulin Degludec14$9,820
ShingrixVaricella-Zoster Ge/As01b/Pf37$8,464
TrintellixVortioxetine Hydrobromide11$7,790
LinzessLinaclotide11$5,856
Advair HfaFluticasone Propion/Salmeterol15$5,783
Omeprazole364$3,865

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$400$148,914127 claims
Novo NordiskOzempic$910$85,49561 claims
Johnson & JohnsonXarelto$367$60,43360 claims
Boehringer IngelheimJardiance, Spiriva Respimat$72$45,40042 claims
AstraZenecaFarxiga, Crestor$390$36,58849 claims
Lilly USA, LLCTrulicity$406$25,74123 claims
GSKBreo Ellipta, Shingrix$568$19,91058 claims
Astellas Pharma US IncMyrbetriq$160$15,97218 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Dexilant$136$11,06723 claims
AbbVieLinzess$1,348$5,85611 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$26$1,896244 claims
Sanofi-aventis U.S. LLCLantus$73$1,45811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →